Saving Vision - Helping people see clearly
| Robert
P. Blau, M.D. |
 |
 Dr. Blau has been providing medical and surgical management for Vitreo-Retinal problems since 1973. He completed his Residency at Sinai Hospital of Detroit and a fellowship in Vitreo-Retinal Surgery at the University of Wisconsin in Madison, WI. He has been in private practice in the Detroit area since that time and is a Clinical Assistant Professor of Ophthalmology at Wayne State University School of Medicine. He has contributed to the understanding of diseases of the retina and vitreous through multiple clinical presentations and publications.
Dr. Blau has special interests in Diabetic Retinopathy, Macular Disorders, Retinal Detachments, and Retinal Vascular Disorders. He was one of the first Doctors in Michigan to utilize Ophthalmic Ultrasound, Retinal Fluorescent Photography, Laser Photocoagulation and Vitreous Surgery in the diagnosis and treatment of Vitreo-Retinal Diseases.
He is certified by the American Board of Ophthalmology and is a fellow of the American Academy of Ophthalmology. He is a member of the American Society of Retinal Specialists, The American Society for Lasers in Medicine and Surgery, The International Society for Ophthalmic Ultrasound, the Michigan Society of Eye Physicians and Surgeons and several others.
He has been Chairman of the Ophthalmology Division, Department of Surgery, at St. Joseph Mercy Oakland Hospital, Pontiac, MI since 2006.
Dr. Blau has privileges at the following hospitals:
- William Beaumont Hospital, Royal Oak, MI
- St. Joseph Mercy Oakland Hospital, Pontiac, MI
- St. John Macomb-Oakland Hospital, Warren, MI
- DMC Sinai-Grace Hospital, Detroit, MI
[top]
| Marshall
N. Cyrlin, M.D. |
|
 Dr. Cyrlin did his Residency in Ophthalmology at the University of Illinois, Eye and Ear Infirmary and a Clinical and Research Fellowship in Glaucoma at Harvard University, Massachusetts Eye and Ear Infirmary. Dr. Cyrlin is Board Certified by the American Board of Ophthalmology and is a Charter Member of the American Glaucoma Society specialty group. Dr. Cyrlin is Emeritus Director of the Glaucoma Service at Beaumont Eye Institute, Royal Oak, Michigan. He has an appointment as Professor of Ophthalmology, Oakland University William Beaumont School of Medicine, and as Clinical Professor of Biomedical Sciences (Ophthalmology), Eye Research Institute, Oakland University, Rochester, MI. He has been actively involved in clinical trials of glaucoma pharmaceutical agents. He has published several book chapters and numerous papers dealing with glaucoma diagnostics and therapeutics and has lectured nationally and internationally. Dr. Cyrlin has received an Honor Award from the American Academy of Ophthalmology and has had multiple listings in Best Doctor’s in America.
Education
- B.A. degree (Biology) Northwestern University, Weinberg College of Arts and Sciences , Evanston, Illinois
- M.D. degree, Washington University, School of Medicine, St. Louis, Missouri
Postgraduate Training
- Medical Internship, Washington University, Barnes-Jewish Hospital St. Louis, Missouri
- Residency in Ophthalmology, University of Illinois, Eye and Ear Infirmary Chicago, Illinois
- Fellowship in Glaucoma , Harvard Univ. School of Medicine, Massachusetts Eye and Ear Infirmary Boston, Massachusetts
Honors and Awards
- B.A. awarded with "Highest Distinction" (Summa Cum Laude), Northwestern University
- Beta Beta Beta (Biology Honorary), Northwestern University
- Marcy Scholar, Northwestern University
- Phi Beta Kappa
- American Academy of Ophthalmology, Honor Award
- Citations in Best Doctors in America (1998, 2002, 2007, 2008, 2009, 2010)
Board Certifications
- Diplomate National Board of Medical Examiners
- Diplomate American Board of Ophthalmology
Professional Societies
- Fellow, American Academy of Ophthalmology
- Charter Member, American Glaucoma Society
- Member, American Society of Cataract and Refractive Surgery
- Member, Association for Research in Vision and Ophthalmology
- Member, Society of Heed Fellows
- Member, American Academy of Ophthalmic Executives
- Member, Michigan Society of Eye Physicians and Surgeons
Current Positions
- Glaucomatologist, Associated Vision Consultants, Southfield, Pontiac, Warren, Michigan
- Emeritus Director, Glaucoma Service, Beaumont Eye Institute, Royal Oak, Michigan
- Professor of Ophthalmology, Oakland University William Beaumont School of Medicine
- Clinical Professor of Biomedical Sciences, Eye Research Institute, Oakland University, Rochester, Michigan
- Member, Alumni Admissions Council, Northwestern University, Evanston, Illinois
- Attending Ophthalmologist
William Beaumont Hospital, Royal Oak, Michigan
St. John Macomb-Oakland Hospital, Warren, Michigan
St. Joseph Mercy Oakland Hospital, Pontiac, Michigan
DMC Huron Valley-Sinai Hospital, Commerce Township, Michigan
Previous Positions
- Clinical Instructor, Ophthalmology, Harvard Univ. School of Medicine, Massachusetts Eye and Ear Infirmary Boston, Massachusetts
- Assistant Clinical Professor of Ophthalmology, Michigan State University, East Lansing, MI
- Assistant Professor of Ophthalmology, Chief, Glaucoma Division, Department of Ophthalmology University of Florida College of Medicine, Gainesville, Florida
- Assistant Professor of Ophthalmology, Chief Resident, Ophthalmology University of Illinois, Eye and Ear Infirmary, Chicago, Illinois
- Instructor, Ophthalmology, Harvard Univ. School of Medicine, Massachusetts Eye and Ear Infirmary Boston, Massachusetts
Research Grants
- Principal Investigator, Director, Advanced Glaucoma Intervention Study, National Eye Institute, Oakland University Center, Michigan
- Co-Investigator, Associate Director, Glaucoma Laser Trial, National Eye Institute, Detroit, Michigan
- Principal Investigator, Protocol PN 001-01, A Phase III, Randomized, Active Comparator- Controlled, Twelve-Week, Double Masked Clinical Trial to Compare the Efficacy and Safety of Preservative-Free MK-2452 (0.0015%) and Preservative-Free Timolol Maleate (0.5%) in Patients with Open-Angle Glaucoma and Ocular Hypertension, Merck & Co., Inc.
- Principal Investigator, Protocol C-07-58, Multidose Anecortave Acetate for Glaucoma with Increased Concentrations, Alcon Laboratories, Ft. Worth Texas
- Principal Investigator, Protocol C-05-13, Patient Dosing with TRAVATAN using the TRAVATAN Dosing Aid, Alcon Laboratories, Ft. Worth, Texas
- Principal Investigator, Protocol CAT-152- 0202, A multicenter randomized, open-label study to compare subconjunctival injections of 100µg human anti-TGFβ2 monoclonal antibody with an intraoperative sponge application of 5-fluorouracil following first time trabeculectomy., Cambridge Antibody Technology, London, England
- Principal Investigator, Protocol 124-00/COS510, A Parallel, Randomized, Observer Masked, Multicenter Study Comparing the Ocular Hypotensive Effect of 2% Dorzolamide Hydrochloride/0.5% Timolol Maleate Combination Ophthalmic Solution to the Concomitant Administration of 0.2% Brimonidine Tartrate Ophthalmic Solution and Timolol Maleate Ophthalmic Solution in Patients with Elevated Intraocular Pressure, Merck & Co., Inc., Whitehouse Station, New Jersey
- Principal Investigator, Protocol CAT-152- 0202, A multicenter randomized, open-label study to compare subconjunctival injections of 100µg human anti-TGFß2 monoclonal antibody with an intraoperative sponge application of 5-fluorouracil following first time trabeculectomy., Cambridge Antibody Technology, London, England
- Principal Investigator, Protocol C-05-13, Patient Dosing with TRAVATAN using the TRAVATAN Dosing Aid, Alcon Laboratories, Ft. Worth, Texas
- Principal Investigator, Protocol C-07-58, Multidose Anecortave Acetate for Glaucoma with Increased Concentrations, Alcon Laboratories, Ft. Worth Texas
- Principal Investigator, Protocol PN 001-01, A Phase III, Randomized, Active Comparator- Controlled, Twelve-Week, Double Masked Clinical Trial to Compare the Efficacy and Safety of Preservative-Free MK-2452 (0.0015%) and Preservative-Free Timolol Maleate (0.5%) in Patients with Open-Angle Glaucoma and Ocular Hypertension, Merck & Co., Inc.
- Principal Investigator, Protocol P-277-5, A Prospective, Multicenter Clinical Trial of the PresVIEW Scleral Implant (PSI) For the Improvement of Near Visual Acuity In Presbyopic Patients, Refocus Group, Inc.
Selected Presentations
- Correlation of Visual Function with Optic Nerve Structure in Glaucoma Suspects. Cyrlin MN, Rosenshein JS: 2nd International Glaucoma Symposium, Jerusalem, Israel, March, 1998.
- Glaucoma Clinical Case Presentations. Cyrlin MN: Optometric Grand Rounds ’98, Troy, Michigan, May, 1998.
- Contact Diode Laser Cyclocoagulation: A Comparison of Shorter-Duration, Higher-Power vs. Longer-Duration, Lower-Power Treatment in Uncontrolled Glaucoma. Cyrlin MN, Tressler CT, Rosensheim JS, Corbin PS: Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, Florida, May, 1998.
- Advances in Glaucoma Diagnostics. Cyrlin MN: Spectrum ’98 Troy, Michigan, October, 1998
- Short-Wavelength-Automated Perimetry, Frequency Doubling Perimetry, and Pattern-Erg Detect Early Glaucomatous Optic Neuropathy. Presentor: Bayer, A., Discussant: Cyrlin, MN: American Academy of Ophthalmology, New Orleans, Louisiana, November 1998.
- Glaucoma Pharmacology Update. Cyrlin MN: Ophthalmology Grand Rounds, William Beaumont Hospital, Royal Oak, Michigan, January, 1999.
- Perspectives in the Medical Management of Glaucoma. Cyrlin MN: East West Eye Meeting, Cleveland, Ohio November 2002
- A Patients Guide to Cataract and Glaucoma. Cyrlin, MN: Guest Speaker, Rotary Organization, Troy, Michigan November 2003
- Central Corneal Thickness (CCT) in the Management of Glaucoma. Cyrlin, MN: Current Concepts in Ophthalmology- Wilmer Eye Institute, San Juan, Puerto Rico February 2004
- he Pharmacologic Management of Wound Healing in Trabeculectomy. Surgery. Cyrlin, MN Current Concepts in Ophthalmology- Wilmer Eye Institute, San Juan, Puerto Rico February 2004
- Role of Anti-Fibrosis Agents in Trabeculectomy Surgery. Cyrlin, MN: Ocular Surgery News Symposium, Glaucoma: Improving Your Odds, Las Vegas, Nevada, June 2004
- Alpha Adrenergic Agents in Glaucoma Management. Cyrlin, MN: Ocular Surgery News Symposium, Glaucoma: Improving Your Odds, Las Vegas, Nevada, June 2004
- Compliance and Adherence in the Management of Glaucoma- When Just Writing a Prescription is not Enough. Cyrlin, MN: Current Concepts in Ophthalmology- Wilmer Eye Institute, San Juan, Puerto Rico, February 2005
- Determination of Target Intraocular pressure in Glaucoma Patients- Why and How to Set Goals. Cyrlin, MN: Current Concepts in Ophthalmology- Wilmer Eye Institute, San Juan, Puerto Rico, February 2005
- Current Concepts in Glaucoma Management. Cyrlin, MN: Contemporary Eye Meeting, Pittsburgh, Pennsylvania, April 2005
- Laser Trabeculoplasty. Cyrlin, MN: Contemporary Eye Meeting, Pittsburgh, Pennsylvania, April 2005
- Determination of Target Intraocular pressure in Glaucoma Patients- Why and How to Set Goals. Cyrlin, MN: Ohio State University, Resident Lecture, Columbus, Ohio, February 2006
- Recent Advances in CSLO (Confocal Scanning Laser Ophthalmoscopy) in Glaucoma Assessment and Management. Cyrlin, MN: Concepts in Ophthalmology- Wilmer Eye Institute, San Juan, Puerto Rico, February 2006
- Current Role of Laser Trabeculoplasty in the Management of Glaucoma. Cyrlin, MN: Concepts in Ophthalmology- Wilmer Eye Institute, San Juan, Puerto Rico, February 2006
- Maximizing Glaucoma Therapy. Cyrlin, MN: Broward County Ophthalmology Society, Fort Lauderdale, FL, April 2008
- Medical Therapy of Glaucoma. Cyrlin, MN: Department of Ophthalmology Grand Rounds. Crittendon Hospital, Rochester, MI. July 2008.
- Medical Management of Glaucoma, Past, Present and Future. Cyrlin, MN: Guest Lecturer, Eye Research Institute, Oakland University, Rochester, MI. November 2009.
Selected Publications
- Cyrlin MN: Automated Perimetry. The Glaucomas. Ritch, R., Shields, M.B., Krupin, T., eds. CV MosbyCo., St. Louis, MO, 2nd Edition 1996; 539-615.
- Rosenshein JS, Cyrlin MN, Fazio R.: Does Cardiac Synchronization Improve Heidelberg Retina Tomograph (HRT) Imaging of the Optic Nerve, Invest Ophthalmol Vis Sci 1996; 37:3, S1091.
- Tressler, C.T., Cyrlin, M.N., Rosenshein, J.S. and Fazio, R.: Subconjunctival Versus Intrascleral Mitomycin-C in Trabeculectomy. Ophth. Surgery and Lasers, 1996; 27:8 661-666.
- Cyrlin, M.N.: Intraocular Pressure Rise Following Laser Surgery. Chandler and Grant’s Glaucoma.. Epstein, D.L., eds, Allingham, R.R., Shuman, J.S. Williams and Wilkins, Baltimore, MD, 1997;
470 - 471.
- Cyrlin MN, Tressler CS, Rosensheim JS, Corbin PS: Contact Diode Laser Cyclocoagulation: A Comparison of Shorter-Duration, Higher-Power vs. Longer-Duration, Lower-Power Treatment in Uncontrolled Glaucoma, Invest Ophthalmol Vis Sci, 1998; 39:4, S471.
- The AGIS Investigators. Advanced Glaucoma Intervention Study (AGIS): 3. Baseline Characteristics of Black and White Patients, Ophthalmology 1998; 105. 1137 1145.
- The AGIS Investigators. Advanced Glaucoma Intervention Study (AGIS): 4. Comparison of Treatment Outcomes within Race, Ophthalmology 1998, 105,1146-1164.
- The AGIS Investigators. Advanced Glaucoma Intervention Study (AGIS) 5. Encapsulated Bleb After Initial Trabeculectomy. American Journal of Ophthalmology, 127:8-19, 1999. (Writing Committee: Schwartz, AL, Van Veldhuisen, PC, Gaasterland, DE, Ederer, F, Sullivan, EK, Cyrlin, MN)
- Cyrlin MN: Malignant Glaucoma. Principles and Practice of Ophthalmology: Clinical Practice 2nd ed. Albert, D.M., Jakobiec, F.A., eds. W. B. Saunders Co., Philadelphia, PA, 1999; 2634-2646.
- The AGIS Investigators:Advanced Glaucoma Intervention Study (AGIS): 7. The Relationship Between Control of Intraocular Pressure and Visual Field Deterioration. American Journal of Ophthalmology, 130:4-429, 2000. (Writing Committee: Van Veldhuisen, PC, Ederer, F Gaasterland, DE, Sullivan, EK, Beck A, Prum BE, Cyrlin, MN, Weiss, H)
- The AGIS Investigators. Advanced Glaucoma Intervention Study (AGIS): 6. Effect of cataract on visual field and visual acuity. Arch. Ophthalmol. In press, November 2000.
- The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 8. Risk of cataract formation after trabeculectomy. Archives of Ophthalmology 2001; 119:1771-1780.
- The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 9. Comparison of glaucoma outcomes in black and white patients within treatment groups. American Journal of Ophthalmology 2001;132:311-320.
- Gaasterland DE, Blackwell B, Dally LG, Caprioli, J, Katz LJ, Ederer F, and the AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 10. Variability among academic glaucoma subspecialists in assessing optic disc notching. Transactions of the American Ophthalmological Society 2001;99:177-185.
- The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. American Journal of Ophthalmology 2002;134:481-498.
- The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 12. Baseline risk factors for sustained loss of visual field and visual acuity in patients with advanced glaucoma. American Journal of Ophthalmology 2002:134:499-512
- The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 13. Comparison of treatment outcomes within race. Ten-year results. Ophthalmology 2004;111:651-664.
- The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 14. Distinguishing Progression of Glaucoma from Visual Field Fluctuations. Ophthalmology 2004;111:2109-2116.
- Cyrlin MN: Target Intraocular Pressure: Protect but do no harm, Glaucoma Management News, 2005; 3:3, 4-5,9.
- Cyrlin MN.: Primary and Secondary Angle Closure Glaucomas. Shacknow, PS, Samples J eds. The Glaucoma Book, A Practical Evidence-Based Approach to Patient Care. Springer, New York, New York 2010; 461-487.
- Cyrlin MN.: Malignant Glaucoma. Shacknow, PS, Samples J, eds. The Glaucoma Book, A Practical Evidence-Based Approach to Patient Care. Springer, New York, New York. 2010;489-497.
- Cyrlin MN.:Intraocular Pressure Rise Following Laser Surgery. Chandler and Grant’s Glaucoma, 5th Edition. Kahook, M, Lee PP, Shuman JS, Epstein, DL, eds.Slack Inc., Thorofare, NJ. 2011 (in press)
Dr. Cyrlin has privileges at the following hospitals:
- William Beaumont Hospital, Royal Oak, MI
- St. Joseph Mercy Oakland Hospital, Pontiac, MI
- St. John Macomb – Oakland Hospital, Warren, MI
- DMC Huron Valley – Sinai Hospital, Commerce Township, MI
[top]
|
